Monday, April 29, 2013

Daily News: Reuters Health News Headlines - Preschools see sharp drop in funding: study

Monday, Apr 29, 2013 11:28 AM PDT
Today's Reuters Health News Headlines - Yahoo! News:

Preschools see sharp drop in funding: study 
Monday, Apr 29, 2013 11:28 AM PDT
To match Insight USA-SCHOOLS/FOREIGNBy Susan Heavey WASHINGTON (Reuters) - Enrollment in U.S. preschools stalled over the past year as states recovering from the recent recession struggle to fund early education for the nation's youngest students, researchers said. In a report released on Monday, education experts pointed to a record drop of more than half a billion dollars in state funding in the 2011-2012 school year from the prior year. The report also found that for the first time in a decade, the percentage of 3- and 4-year-olds enrolled did not grow. Overall, 1.3 million children attended state-run preschools in 2011-2012. ...
Full Story
Top
South Africa's Mandela frail in first TV footage in months 
Monday, Apr 29, 2013 11:23 AM PDT
Former South African president Nelson Mandela looks on as he celebrates his birthday at his house in QunuJOHANNESBURG (Reuters) - Anti-apartheid hero Nelson Mandela made his first television appearance in almost a year on Monday, looking thin and frail in his Johannesburg home where he has been resting after a bout of pneumonia. The veteran leader stared mostly straight ahead, his face showing little expression in the footage of a visit from President Jacob Zuma and other officials, shown by state broadcaster SABC. ...
Full Story
Top
Merck, Pfizer to jointly develop diabetes drug 
Monday, Apr 29, 2013 11:20 AM PDT
A view of the Merck & Co. campus in Linden, New JerseyBy Ransdell Pierson (Reuters) - Pfizer Inc and Merck & Co Inc said they will co-develop Pfizer's experimental type 2 diabetes drug ertugliflozin, both as a standalone product and in combination with other drugs, including Merck's blockbuster Januvia. The Pfizer medicine belongs to a new class of diabetes treatments called SGLT2 inhibitors. Now nearing Phase III late-stage trials, it is behind similar drugs in development -- including Johnson & Johnson's Invokana (canagliflozin) which was approved by U.S. regulators in late March. ...
Full Story
Top
Five convicted in Kosovo organ trafficking case 
Monday, Apr 29, 2013 10:38 AM PDT
Judges attend the trial of urologist Lutfi Dervishi and his colleagues accused of organ trafficking, in PristinaBy Fatos Bytyci PRISTINA (Reuters) - Five men were convicted in Kosovo on Monday of involvement in an organ trafficking ring that performed at least 23 illegal kidney transplants at a clinic on the outskirts of the capital, under the noses of United Nations police and NATO peacekeepers. The trial of the men, all citizens of Kosovo, has taken on added significance in the region because it echoes a high-profile probe into alleged organ harvesting by guerrilla fighters during the 1998-99 war. ...
Full Story
Top
Mother forced daughter, 14, into sperm insemination - UK court 
Monday, Apr 29, 2013 09:27 AM PDT
By Estelle Shirbon LONDON (Reuters) - A mother who persuaded her adopted teenage daughter to become pregnant by artificial insemination because she wanted a baby for herself has been jailed for five years in Britain, in a case that raises concern over how easily donor sperm can be obtained. Previously secret court documents showed that the daughter, a virgin, was made to inseminate herself alone in her bedroom seven times over a two-year period starting in 2008 when she was 14, using syringes of semen bought online by the mother from sperm bank Cryos in Denmark. ...
Full Story
Top
Auxilium cuts sales view on drugs, expands urology business 
Monday, Apr 29, 2013 09:21 AM PDT
(Reuters) - Auxilium Pharmaceuticals Inc reported a big fall in quarterly sales in the United States for both its drugs, and said it acquired Actient Holdings LLC to bolster its urology business. Shares of Auxilium fell as much as 13.5 percent to $13.87 — their lowest in a year-and-a-half — on the Nasdaq on Monday. Revenue fell 10 percent in the first quarter to $66.2 million, below analysts' average estimate of $81.23 million, according to Thomson Reuters I/B/E/S. Testosterone gel Testim's sales, almost all of which come from the United States, fell 23 percent to $45.5 million. ...
Full Story
Top
Tabata metes out fitness in short, repeated flashes 
Monday, Apr 29, 2013 07:27 AM PDT
Jogger passes fitness enthusiasts performing stretching exercises after sunrise at Queenscliff Beach in SydneyBy Dorene Internicola NEW YORK (Reuters) - For people who are too bored or busy to spend an hour on a treadmill an exercise regime that was developed for athletes but is being taught in gyms may help to build fitness in less time. The Tabata Protocol is a four-minute regime that measures fitness in seconds - 20 seconds of full-out work followed by 10 seconds of rest, repeated eight times. Although it can boost fitness levels of the healthy and time-pressed, experts say it is not for everybody and should not be done every day. ...
Full Story
Top
China reports latest bird flu death 
Monday, Apr 29, 2013 06:48 AM PDT
Health officers examine a pigeon for H7N9 at a poultry market in ChangshaBEIJING (Reuters) - A man in Shanghai died from bird flu on Monday, the latest person to die from the H7N9 strain of the virus first discovered in humans in March that has now killed at least 24 people. The 89-year-old died after 12 days of medical treatment, state news agency Xinhua said, citing Shanghai health authorities. Cases of the virus, confirmed in well over 100 people, have spread to several new provinces in recent days, including Fujian and Hunan. Last week a man in Taiwan became the first case of the flu outside mainland China. He caught the flu while travelling in China. ...
Full Story
Top
South Africa's Mandela in good health, good spirits: ANC 
Monday, Apr 29, 2013 06:45 AM PDT
(Blank Headline Received)JOHANNESBURG (Reuters) - Anti-apartheid hero Nelson Mandela is in good health and good spirits, South Africa's ruling African National Congress said on Monday, in the first update on his condition since he was discharged from hospital in early April. President Jacob Zuma and other party leaders visited the 94-year-old former president at his Johannesburg home. "After receiving a briefing from the medical team, the national officials are satisfied that President Mandela is in good health and is receiving the very best medical care," the ANC said. ...
Full Story
Top
FDA rejects two Gilead HIV drugs as standalone products 
Monday, Apr 29, 2013 06:35 AM PDT
By Toni Clarke WASHINGTON (Reuters) - Gilead Sciences Inc said on Monday that U.S. health rejected two of its HIV drugs as standalone therapies, citing deficiencies in documentation and validation of certain quality testing procedures. Gilead said it is working with U.S. Food and Drug Administration to address the questions raised in the rejection letter in order to prove the application forward. The company is seeking approval for its drug elvitegravir for people with HIV, the virus that causes AIDS, who have already been treated with other products. ...
Full Story
Top
Impax, GSK end Parkinson's disease partnership 
Monday, Apr 29, 2013 06:07 AM PDT
(Reuters) - Impax Laboratories Inc said partner GlaxoSmithKline Plc ended their collaboration on Impax's experimental Parkinson's disease drug due to regulatory and launch delays in the countries in which GSK has rights to market the drug. Impax shares fell 2 percent to $17.32 in premarket trade after closing at $17.62 on Friday on the Nasdaq. Under a deal, GlaxoSmithKline had the right to develop and market the drug, IPX066, outside the United States and Taiwan. Rights to the drug, which is known as Rytary in the United States, will transfer back to Impax at the end of July 2013. ...
Full Story
Top
EU drugs agency recommends suspension of tetrazepam 
Monday, Apr 29, 2013 04:27 AM PDT
LONDON (Reuters) - EU drugs regulators have recommended suspending use of all tetrazepam-containing medicines following reports of serious skin reactions, the European Medicines Agency said on Monday. Tetrazepam belong to a class of drugs known as benzodiazepines and is used in several European Union countries to treat conditions such as back and neck pain and spasticity. (Reporting by Kate Kelland, editing by Ben Hirschler)
Full Story
Top
Bayer to buy birth-control devices maker for $1.1 billion 
Monday, Apr 29, 2013 03:48 AM PDT
The logo of Germany's largest drugmaker Bayer HealthCare Pharmaceuticals is pictured on the front of its building in BerlinBy Ludwig Burger FRANKFURT (Reuters) - Germany's Bayer AG has agreed to buy U.S. contraceptive devices maker Conceptus for $1.1 billion, aiming to underpin its position as the world's largest women's healthcare provider, Bayer, whose shares were down 2.3 percent by 0823 GMT, will launch a public tender offer to acquire all Conceptus shares for $31.00 each in cash, in an offer agreed with Conceptus's management, Bayer said on Monday. That is a premium of 19. ...
Full Story
Top
Respect women's choice to have home birth: doctors 
Sunday, Apr 28, 2013 09:09 PM PDT
A pregnant woman touches her stomach as people practice yoga on the morning of the summer solstice in New York's Times SquareBy Genevra Pittman NEW YORK (Reuters Health) - Although hospitals and birthing centers are the safest places to have a baby, pediatricians said today that women who choose to give birth at home should be supported and that setting made as safe as possible, as well. Planned home birthing, they said, may be an option for healthy moms-to-be who are due to have a single, on-time baby. A certified nurse-midwife, midwife or doctor should be present and a previous agreement made with a nearby hospital in case transfer is needed, according to the American Academy of Pediatrics (AAP) policy statement. ...
Full Story
Top
In abortion debate, both sides point to Philadelphia trial 
Sunday, Apr 28, 2013 09:04 PM PDT
Full Story
Top

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.

No comments:

Post a Comment